Clinical Trial Study on the Improved New Method of Acupotomy for AS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorChina-Japan Friendship Hospital

About this trial

This study employs a randomized controlled trial methodology to systematically evaluate the efficacy and safety of a modified acupotomy technique in the treatment of ankylosing spondylitis. Through ultrasound-guided localization, the operative sites are assessed to clarify the improvement effect of the modified acupotomy on disease activity in AS patients. The aim is to enhance the clinical outcomes of AS, provide evidence-based medical support for acupotomy treatment of AS, and improve the diagnosis and treatment standards for the condition.

Eligibility criteria

Qualifiers

Meeting the 1984 revised New York criteria or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis

Age 18-75 years

BASDAI ≥4

Signed informed consent form

Disqualifiers

Presence of autoimmune diseases other than the studied condition

Complete spinal ankylosis or spinal deformity

Pregnant or lactating women

Comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, malignant tumors, or coagulation disorders

Trial design

Treatments tested in this trial

  • Acupotomy
  • Sham Acupotomy

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

China-Japan Friendship Hospital

Lead sponsor

The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine

Collaborator